INTELLIA THERAPEUTICS, INC. (NTLA) Net margin 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) net profit margin by fiscal year — reported net income divided by reported revenue.
-609.9%FY2025 · since FY2016: -192.0% → -609.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -609.9% | +286.9 pp |
| FY2024 | -896.8% | +429.7 pp |
| FY2023 | -1326.5% | -416.7 pp |
| FY2022 | -909.8% | -99.3 pp |
| FY2021 | -810.5% | -579.0 pp |
| FY2020 | -231.5% | +868.7 pp |
| FY2019 | -1100.1% | -819.7 pp |
| FY2018 | -280.4% | -21.8 pp |
| FY2017 | -258.6% | -66.7 pp |
| FY2016 | -192.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NTLA financial trends
NTLA RevenueNTLA Net incomeNTLA Gross profitNTLA Gross marginNTLA Operating incomeNTLA Operating marginNTLA Operating cash flowNTLA Free cash flowNTLA Capital expendituresNTLA Return on equityNTLA Stock buybacksNTLA Dividends paidNTLA Total assetsNTLA Total liabilitiesNTLA Shareholders’ equityNTLA overview →